Recurrent erysipelas: 47 cases
Clicks: 384
ID: 114517
2007
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
384 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #1 of 6 articles by views in dermatology (basel, switzerland)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Our results showed that erysipelas recurrence has the same risk factors as single episodes and underlines the potential benefit of oral or parenteral antibiotic prophylaxis to prevent recurrences.
| Reference Key |
s2007dermatologyrecurrent
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Leclerc S;Teixeira A;Mahé E;Descamps V;Crickx B;Chosidow O;; |
| Journal | dermatology (basel, switzerland) |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
prognosis
adult
female
male
age factors
aged
middle aged
risk factors
80 and over
Incidence
Retrospective Studies
follow-up studies
erysipelas* / diagnosis
o chosidow
anti-bacterial agents / therapeutic use*
secondary prevention
pmid:17191048
doi:10.1159/000096913
s leclerc
a teixeira
antibiotic prophylaxis / methods*
erysipelas* / drug therapy
erysipelas* / epidemiology
no. 1
dermatology 2007
vol. 214
232639
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.